Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Umasankar Kulandaivelu has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Rasool et al. Non-Invasive Delivery of Nano-Emulsified Sesame Oil-Extract of Turmeric Attenuates Lung Inflammation. Pharmaceutics 2020, 12, 1206

    by Sahibzada Tasleem Rasool, Rajasekhar Reddy Alavala, Umasankar Kulandaivelu, Nagaraja Sreeharsha

    In the original publication, there was a mistake in Figure 8 as published

  • Open Access

    Neuroprotective and nootropic evaluation of Myristica malabarica on diabetes-induced cognitive impairment in experimental animals: Promising for controlling the risk of Alzheimer’s disease

    by Kolguri Jagadeeshwar, Rajasekhar Reddy Alavala, Subhakar Raju Ravula, Umasankar Kulandaivelu, G.S.N. Koteswara Rao

    This study intends to explore the neuroprotective and memory-enhancing properties of Myristica malabarica (MM) leaf extracts on diabetic-induced cognitive decline rats. The models of Y maze and Morris water maze were selected for nootropic activity and neuroprotective properties were deliberate by assessing the levels of Ach, malondialdehyde (MDA), superoxide dismutase (SOD), nitric oxide (NO), catalase (CAT) and glutathione hormone (GSH) in diabetic rat brains. Significantly improved memory and learning with 100 mg/kg (P < 0.01) and 200 mg/kg (P < 0.001) of EAMM (L) and MAMM (L) in Y maze and Morris water maze models. Significant effect was observed in all the extracts with two doses when compared with diabetic control on day 75. The levels of AChE (P < 0.001), MDA (P < 0.01), and NO (P < 0.05) were decreased significantly and significantly raised (P < 0.01) levels of SOD, CAT, and GSH with MAMM (100 and 200 mg/kg) compared with disease control. Further studies on MM leaf are needed as evidence of cognitive impairment in defense against diabetes has been shown to expose its mode of action.

  • AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants

    by Bikash Ranjan Jena, Siva Prasad Panda, Umasankar Kulandaivelu, Rajasekhar Reddy Alavala, G.S.N Koteswara Rao, Suryakanta Swain, Gurudutta Pattnaik, Debashish Ghose

    Abiraterone acetate is a well-known anticancer drug and a steroidal derivative of progesterone for treatment of patients with hormone-refractory prostate cancer. Chemometrics-assisted reverse phase high performance liquid chromatography (RP-HPLC) development of the drug abiraterone acetate has been employed in this study using an analytical quality by design (AQbD) approach. Drug separation was performed using a Princeton Merck-Hibar Purospher STAR (C18, 250 mm × 4.6 mm) i.d., 5 μm particle size) with ultraviolet detection at 235 nm. A Box-Behnken statistical experimental design with response surface methodology was executed for method optimization and desired chromatographic separation from its formulation with a few numbers of experimental trials. The impact of three independent variables, namely, composition of the mobile phase, pH, and flow rate, on response retention time and peak area was studied by constructing an arithmetic model from these variables. Optimized experimental conditions for the proposed work include the mobile phase acetonitrile and phosphate buffer (10 mM KH2PO4) (20:80 %v/v). At the concentration range of 2-100 μg/mL, a linear calibration curve was found. Recovery was performed at three concentrations and was foun to be between 98% and 102%. The 3D response surface curves revealed that mobile phase composition and flow rate were the most substantial critical factors affecting desired responses. An attempt has been made to develop and validate an economical, precise, robust, stability-indicating AQbD-based RP-HPLC method that can be employed successfully for the routine analysis of abiraterone acetate in quality control labs.


  • Symphony of the DNA flexibility and sequence environment orchestrates p53 binding to its responsive elements

    by Akkinepally Vanaja, Sarada Prasanna Mallick, Umasankar Kulandaivelu, Aditya Kumar, Venkata Rajesh Yella


  • Open Access

    Protective effect of Acampe praemorsa (Roxb.) Blatt. & McCann against oxidative stress

    by U Praveen Kumar, Gsn Koteswara Rao, A Rajasekhar Reddy, K Umasankar, Y Vangoori

    The current study was carried to make available phytochemical information and evaluation of antioxidant activity of Acampe praemorsa (Roxb.) Blatt. & McCann. The phytochemical analysis was carried out using procedures and quantified phenolic and alkaloid contents. The antioxidant activity was evaluated by in-vitro and in-vivo studies. The In-vitro antioxidant activity was carried on free radicals such as superoxide, hydroxyl DPPH, hydrogen peroxide, evaluation of reducing power. In-vivo study was carried on albino Wistar rats with different doses of extracts. The results provide that, A. praemorsa extracts have diversified phytochemicals in extracts like steroids, alkaloids, phenolics, glycosides, oils, quinones, tannins etc. The hydroalcoholic extract has more phenolic (26.80±0.51) and alkaloid (20.59±0.22) contents. The antioxidant activity results provide information that the extracts possess concentration dependent activity on tested free radicals. The hydroalcoholic extract has more protective nature against superoxide, DPPH, H2O2 free radicals and reducing power but ethyl acetate extract has more potential against hydroxyl free radical than hydroalcoholic extract. The extracts were found to be safe on toxic studies and In-vivo study results and they play significant role in controlling the oxidative enzymes such as catalase, superoxide dismutase, lipid peroxidation (malonaldehyde) in the body. Thus, it was determined that A. praemorsa have potential bioactive compounds and antioxidant activity.

  • Applications of QbD-based Software’s in Analytical Research and Development

    by Bikash Ranjan Jena, Siva Prasad Panda, Kulandaivelu Umasankar, Suryakanta Swain, Gudhanti Siva Naga Koteswara Rao, Dalu Damayanthi, Debashish Ghose, Debi Prasad Pradhan

    Background: Quality by design-based software’s in analytical research and development normally encompasses multiple objectives. For decades, this task has been attempted through trial and error, supplemented with the previous experience, knowledge, and wisdom of analytical researchers. Objective: The study analyzes the current QbD-assisted software’s, such as design-experts, minitab, fusion product development, etc., and its broad implementations in an analytical research and development. Methods: The traditional approach may fails to meet the intended purpose by trial and error procedure during analytical research and development. However, modern scientific technology is equipped with highly advanced features associated with the software of the QbD paradigm. The impact and interactions between the critical process variables and critical method attributes such as resolution, tailing, etc. can be well understood by the screening, optimization, and robustness studies based on the principles of experimental design. Results: The design of experiments assimilate statistical multi-variate analysis instead of one factor at a time approach. This also provides a prominent, most reliable quality output, which is also essential for getting highly robust method as well as to obtain homogenous product development. Conclusion: The present review, critically discussed about the various QbD based multivariate software and their applications in drug development and analytical research.


  • Open Access

    Non-Invasive Delivery of Nano-Emulsified Sesame Oil-Extract of Turmeric Attenuates Lung Inflammation

    by Sahibzada Tasleem Rasool, Rajasekhar Reddy Alavala, Umasankar Kulandaivelu, Nagaraja Sreeharsha

    Turmeric, the golden Indian spice, and the edible oil of sesame seeds are the essential ingredients of Indian food created by ancestors and established the belief of the curative effect of food for many generations. Considering the anti-inflammatory effects of turmeric, we formulated a nano-emulsion of turmeric infused in edible sesame oil, with a globule size of 200–250 nm using high-energy microfluidization. The product with a zeta potential of −11.5 mV showed spherical globules when imaged for scanning and transmission electron microscopy. We explored the anti-inflammatory potential of this edible nano-emulsion in lung inflammation. The lungs are the internal organ most vulnerable to infection, injury, and rapid inflammation from the external environment because of their constant exposure to pollutants, pathogenic microorganisms, and viruses. We evaluated the nano-emulsion for efficacy in ovalbumin-induced lung injury in mice with an oral treatment for two weeks. The therapeutic effect of nano-emulsion of the sesame oil-extract of turmeric was evident from biochemical analysis of bronchoalveolar lavage fluid, lung histopathology, and flow cytometric analysis. The developed nano-emulsion significantly reduced the inflammation and damage to the alveolar network in ovalbumin-injured mice. Significant reduction in the levels of neutrophils and inflammatory cytokines like IL-4, IL-6, and IL-13 in bronchoalveolar lavage fluid was observed in the nano-emulsion-treated group. Leukotriene B4 and IgE were also significantly altered in the treated group, thus suggesting the suitability of the formulation for the treatment of allergy and other inflammatory conditions. The nano-emulsification process potentiated the immunoregulatory effect of turmeric, as observed from the elevated levels of the natural anti-inflammatory cytokine, IL-10. The dietary constituents-based nano-emulsion of spice turmeric helped in scavenging the free radicals in the injured lungs, thus modulating the inflammation pathway. This easily scalable formulation technology approach can therefore serve as a potential noninvasive and safe treatment modality for reducing lung inflammation in lung injury cases.


  • Risk Assessment, Screening and Control of Elemental Impurities in Pharmaceutical Drug Products: A Review

    by Rajesh Kumar Chawla, Subhranshu Panda, Kulandaivelu Umasankar, Siva Prasad Panda, Dalu Damayanthi

    This article describes and reviews the steps involved in risk assessment of the twenty-four (24) potential elemental impurities in pharmaceutical drug products, as per the permitted daily exposure limits. Screening and estimation of prescribed elemental impurities in pharmaceutical drug substances, inactive excipients and drug products by inductively coupled plasma mass spectrometry or inductively coupled plasma optical emission spectrometry and their controls involved are also reviewed, as referred in the general chapters & of the United States Pharmacopoeia, Q3D guideline for elemental impurities as per international conference on harmonization and q3d elemental impurities: guidance for industry as per U. S., Food and Drug Administration USFDA.


  • Open Access

    Studies on Antidiabetic Activity of Atylosia Albicans in Streptozotocin-Induced Diabetic Rats

    by Sharvana Bhava B S, Umasankar K, Kottai Muthu A

    The present study was aimed to investigate the Antidiabetic effect of Atylosia Albicans extracts in streptozotocin-induced diabetes in Wistar rats. Rats have fasted overnight, and the plant extracts at doses 100 and 200 mg/kg were administered for 14 days. Streptozotocin was used to induce diabetes mellitus. The standard hypoglycaemic agent selected for this work was Glibenclamide (10 mg/kg). The different test solutions at doses 100 and 200 mg/kg of petroleum ether, ethyl acetate and methanolic extracts respectively were given a respective group of rats. The anti-diabetic potential was assessed by determining oral glucose tolerance, fasting blood glucose, Blood glucose levels, glycated hemoglobin (HbA1c), total cholesterol (TC), triglycerides (TG), high‑density lipoproteins (HDL), low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) were evaluated parameters. The methanolic extract with 200 mg/kg was more significant in anti-diabetic activity (P<0.001) on the 14th day and also significantly decreased TG, TC, VLDL‑C, LDL‑C and HbA1c (P<0.001) when compared to diabetic control rats. From the obtained results, it can be revealed that the methanolic extract of Atylosia Albicans has great potent antidiabetic activity. The results suggest that Triumfetta rotundifolia has anti-diabetic activity, thereby justifying its traditional use.

  • Evaluation of Antiulcer Activity of Lawsonia inermis and Murraya koenigii Seed Extract in Ethanol-induced Gastric Mucosal Damage in Rats

    by Venkateshwarlu Eggadi, Jhansi Lingampall, Srinivasulu Kamma, Sharavana Bhava Shes Bandaru, Rajasekhar Reddy Alavala, Umasankar Kulandaive